US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wag! Group Co

0.1200

-0.0374-23.76%

Post-market: 0.12500.0050+4.17%19:55 EDT

Volume:1.89M

Turnover:255.95K

Market Cap:6.09M

PE:-0.31

High:0.1675

Open:0.1553

Low:0.1100

Close:0.1574

Loading ...

Overview Company News Filings

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

Telix Says First Patient Administered Drug Candidate in Trial for Soft Tissue Sarcoma

MT Newswires Live

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

Gurit Finalizes Sale of Italian PET Recycling Site

Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

GE HealthCare's Latest Product Launch to Boost Cardiology Care

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway

Loop Industries to Participate in Gabelli Funds' 11th Annual Waste & Sustainability Symposium

ACCESS Newswire

Wag! Group Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

Top Midday Decliners

MT Newswires Live

Wag! Group Co reports results for the quarter ended December 31 - Earnings Summary

Wag! Group 2025 Outlook: Expects Revenues Of $84M-$88M Vs. $75.30M Est., Sees Adjusted EBITDA Of $2M-$4M

Wag Group Q4 2024 GAAP EPS $(0.10) Misses $(0.05) Estimate, Sales $15.43M Miss $18.90M Estimate

Wag! Group Co: Q4 Loss per Share $0.10

THOMSON REUTERS

Wag! Group Q4 Revenue USD 15.4 Million

THOMSON REUTERS

Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value

THOMSON REUTERS

Press Release: Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value

Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure

Wag! Group Co expected to post a loss of 5 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PET/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","market":"US","secType":"STK","nameCN":"Wag! Group Co","latestPrice":0.12,"timestamp":1743624000000,"preClose":0.1574,"halted":0,"volume":1887900,"hourTrading":{"tag":"盘后","latestPrice":0.125,"preClose":0.12,"latestTime":"19:55 EDT","volume":217252,"amount":27907.4805,"timestamp":1743638129691},"delay":0,"floatShares":22064454,"shares":50733823,"eps":-0.392853,"marketStatus":"Closed","change":-0.0374,"latestTime":"04-02 16:00:00 EDT","open":0.1553,"high":0.1675,"low":0.11,"amount":255949.456077,"amplitude":0.365311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.392853,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1574,"preHourTrading":{"tag":"盘前","latestPrice":0.1636,"preClose":0.1557,"latestTime":"08:49 EDT","volume":434,"amount":71.40430570000001,"timestamp":1743598182141},"postHourTrading":{"tag":"盘后","latestPrice":0.125,"preClose":0.12,"latestTime":"19:55 EDT","volume":217252,"amount":27907.4805,"timestamp":1743638129691},"volumeRatio":8.624368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","floatShares":22064454,"roa":"-16.97%","roe":"-3036.82%","lyrEps":-0.392853,"volumeRatio":8.624368,"shares":50733823,"dividePrice":0,"high":0.1675,"amplitude":0.365311,"preClose":0.1574,"low":0.11,"week52Low":0.11,"pbRate":"-12.45","psRate":"0.09","week52High":2.47,"institutionHeld":0,"latestPrice":0.12,"eps":-0.392853,"divideRate":0,"volume":1887900,"delay":0,"ttmEps":-0.392853,"open":0.1553,"prevYearClose":0.2383,"prevWeekClose":0.1716,"prevMonthClose":0.1531,"prevQuarterClose":0.1531,"fiveDayClose":0.1902,"twentyDayClose":0.2532,"sixtyDayClose":0.3003},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PET\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524146431","title":"Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2524146431","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524146431?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:30","pubTimestamp":1743593400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 02, 2025  -- Biogen Inc.  today announced that the U.S. Food and Drug Administration  has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide  therapy targeting tau, for the treatment of Alzheimer’s disease. Fast Track designation is intended to facilitate the development and expedite the review of investigational drugs that treat serious conditions and address unmet medical needs.About BIIB080BIIB080 is an investigational antisense oligonucleotide  therapy designed to target microtubule-associated protein tau  mRNA to reduce the production of tau protein. Abnormal accumulation of tau in the brain is a hallmark of Alzheimer’s disease and is associated with neurodegeneration and cognitive decline. BIIB080 is currently being evaluated in a Phase 2 clinical study  in individuals with early Alzheimer’s disease.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biogen-investigational-tau-targeting-therapy-113000529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4561","IE00B19Z9P08.USD","IE00BFXG0V08.USD","IE00B894F039.SGD","BK4567","IE00B19Z9Z06.USD","CSF","BK4104","BK4192","BK4023","BK4588","LU0320765992.SGD","BK4200","PET","ASO","LU0889565916.HKD","FAST","MAPT","BK4532","IE00BYQQ9H92.USD","LU0109394709.USD","LU0234570918.USD","BK4585","BK4533","IE00B5TLWC47.USD","BK4139","BIIB"],"gpt_icon":0},{"id":"2524818124","title":"Telix Says First Patient Administered Drug Candidate in Trial for Soft Tissue Sarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2524818124","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524818124?lang=en_us&edition=fundamental","pubTime":"2025-04-02 13:19","pubTimestamp":1743571140,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said the first patient has been administered its drug candidate TLX300-CDx in the Phase 1 ZOLAR1 trial for advanced metastatic soft tissue sarcoma , according to a Tuesday statement by the company.The trial aims to assess the drug's biodistribution, safety, and optimal dose using positron emission tomography , the statement said.TLX300-CDx targets PDGFRα, a protein often over-expressed in STS, the statement added.The study will inform future therapeutic approaches for treating the disease, the company said.Telix holds the rights to develop and commercialize the radiolabelled drug, the company added.Shares of the company fell 3% on market close.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4192","BK7067","BK7047","PET.AU","TLX.AU","PET"],"gpt_icon":0},{"id":"2524126511","title":"Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126511","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126511?lang=en_us&edition=fundamental","pubTime":"2025-04-02 03:30","pubTimestamp":1743535800,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, April 02, 2025  -- Telix Pharmaceuticals Limited  today announces that a first patient has been dosed in the Phase 1 ZOLAR1 trial of TLX300-CDx  in patients with advanced, metastatic soft tissue sarcoma  at the Melbourne Theranostic Innovation Centre  in Melbourne, Australia.The aim of the trial is to evaluate the safety, pharmacokinetics, biodistribution and dosimetry, and establish the optimal dose of TLX300-CDx in patients with advanced STS, prior to therapeutic studies, based on a theranostic approach. As part of the study, it is also expected that the patient dosimetry and target expression characteristics will inform the final selection of therapeutic radionuclide for this candidate, in conjunction with currently active non-clinical radiation biology studies.Telix intends to develop a novel targeted radionuclide therapy, specific for PDGFRα, which could be used to treat patients with STS. Telix holds the exclusive worldwide rights to develop and commercializ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telix-announces-first-patient-dosed-193000667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7067","XKO.AU","IE00B19Z4B17.USD","PET.AU","BK4141","SEC.AU","XAO.AU","ASX","XJO.AU","BK7047","PET","BK4139","IE0031619046.USD","BK7039","BK4157","BK4543","ASX.AU","TLX","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4192","TLX.AU","AEIS","BK4526"],"gpt_icon":0},{"id":"2524141730","title":"Gurit Finalizes Sale of Italian PET Recycling Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2524141730","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524141730?lang=en_us&edition=fundamental","pubTime":"2025-04-02 00:03","pubTimestamp":1743523427,"startTime":"0","endTime":"0","summary":"Gurit Holding AG ( ($CH:GURN) ) has provided an announcement. Gurit Holding AG has completed the divestment of its PET recycling site in Carmignano...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gurit-finalizes-sale-of-italian-pet-recycling-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gurit-finalizes-sale-of-italian-pet-recycling-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2524130734","title":"Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2524130734","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524130734?lang=en_us&edition=fundamental","pubTime":"2025-04-01 14:00","pubTimestamp":1743487200,"startTime":"0","endTime":"0","summary":"TORONTO, April  01, 2025  (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3052978/0/en/Quantum-BioPharma-Announces-Joint-Clinical-Study-With-Massachusetts-General-Hospital-Scientists-to-Validate-a-Novel-Positron-Emission-Tomography-PET-Imaging-Technique-to-Monitor-De.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU2028103732.USD","PET","BK4596","LU2089284900.SGD","LU0225283273.USD","LCID","BK4504","LU1989772923.USD","BK4192","BK4185","LU0106261372.USD","LU1162221912.USD","LU2023251221.USD","BK4516","BK4007","LU2271345857.HKD","LU1989772840.SGD","BK4534","BK4585","LU2111349929.HKD","BK4588","LU0098860793.USD","BK4581","LU1732799900.SGD","LU1732800096.USD","BK4099","LU0267386448.USD","LU0795875086.SGD","LU0795875169.SGD","LU0158827781.USD","LU1720051017.SGD","LU2357305700.SGD","QNTM","LU0006306889.USD","JYNT","LU1363072403.SGD","BK4127","LU1720051108.HKD","LU2089283258.USD","BK4555","BK4551","LU2347655156.SGD","LU1074936037.SGD","IE00BKVL7J92.USD","LU0314104364.USD","LU0912757837.SGD","LU0320765646.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2523492666","title":"GE HealthCare's Latest Product Launch to Boost Cardiology Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2523492666","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523492666?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:45","pubTimestamp":1743428700,"startTime":"0","endTime":"0","summary":"GE HealthCare Technologies Inc. GEHC recently announced the U.S. launch of Flyrcado  injection at the ongoing American College of Cardiology  Annual Scientific Session & Expo. It also plans to unveil the latest version of CASE , powered by its CardioSoft technology, at the ACC.GE HealthCare also plans to showcase CardIQ Suite  and its recently launched AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab editions.GEHC aims to highlight its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway by showcasing its latest AI-powered innovations.The latest launch is expected to significantly strengthen GE HealthCare’s Cardiology Solutions unit, thus boosting its overall business.GEHC further stated that the FDA approved Flyrcado for patients with known or suspected CAD in 2024. This is expected to deliver higher diagnostic efficacy, unlike SPECT MPI, the predominant procedure used in nuclear cardiology at present.GE He","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ge-healthcares-latest-product-launch-134500646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765489.SGD","LU2023251221.USD","SG9999004303.SGD","BK4187","LU0496365809.HKD","LU0211326755.USD","IE0002141913.USD","LU1061106388.HKD","MMSI","LU0122379950.USD","BK4566","LU1093756168.USD","LU0208291251.USD","BK4504","LU1914381329.SGD","LU1261432733.SGD","BK4192","LU1064131342.USD","LU1989764748.USD","LU1721429741.USD","LU1894683348.USD","BK4501","LU0868494617.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","MDT","LU1559883803.SGD","LU0566484027.USD","IE00B3T34201.USD","PET","IE00B4R5TH58.HKD","GEHC","IE000M9KFDE8.USD","LU2089984988.USD","LU2089284900.SGD","IE0009355771.USD","LU1894683264.USD","LU0157215616.USD","LU2089283258.USD","LU1291159041.SGD","BK4588","ABT","LU0820561909.HKD","LU1093756325.SGD","CMS","BK4585","GE","BK4533","SG9999002224.SGD"],"gpt_icon":0},{"id":"2523917675","title":"Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917675","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917675?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical mu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052163/36461/en/Voyager-Presents-Robust-Preclinical-Data-from-Tau-Targeting-Gene-Therapy-and-Antibody-Programs-at-AD-PD-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK4023","LU1169590202.USD","CTA","PD","PET","LU1169589451.USD"],"gpt_icon":0},{"id":"2522306104","title":"ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2522306104","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522306104?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:00","pubTimestamp":1743080400,"startTime":"0","endTime":"0","summary":"The much-anticipated Flyrcado  injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, is now available in select U.S. markets and has been granted traditional pass-through payment status by the U.S. Centers for Medicare and Medicaid.CHICAGO, March 27, 2025----GE HealthCare  today announced the U.S. launch of Flyrcado  injection at the 2025 American College of Cardiology  Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway. GE HealthCare has been investing in AI for years and has topped the FDA list of AI-enabled device authorizations for three years in a row with 85 authorizations.i. Today, GE HealthCare announced the commercial launch of Flyrcado, a first-of-its-kin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acc-2025-ge-healthcare-announces-130000365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1894683348.USD","LU1551013342.USD","BK4566","LU1894683264.USD","LU2264538146.SGD","LU0640476718.USD","LU0689472784.USD","LU2637428348.USD","LU0354030511.USD","LU1064131342.USD","LU1551013425.SGD","GEHC","BK4585","BK4192","LU0943347566.SGD","LU0820562030.AUD","BK4206","LU2543165471.USD","LU0157215616.USD","LU0354030438.USD","LU1093756325.SGD","BK4588","LU0124676726.USD","LU0149725797.USD","BK4543","LU2500361329.USD","LU0820561818.USD","LU1261432733.SGD","LU1093756168.USD","LU2346227817.USD","LU1988902786.USD","BK4082","BK4501","LU0868494617.USD","BK4208","BK4187","LU1280957306.USD","LU0820561909.HKD","GE","PET","LU1366333091.USD","LU2756315318.SGD","LU0689626769.HKD","LU2756315664.SGD","CMS"],"gpt_icon":0},{"id":"2522372413","title":"Loop Industries to Participate in Gabelli Funds' 11th Annual Waste & Sustainability Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2522372413","media":"ACCESS Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522372413?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076800,"startTime":"0","endTime":"0","summary":"MONTREAL, QC / ACCESS Newswire / March 27, 2025 / Loop Industries, Inc.  , a clean technology company dedicated to acceleratinga circular plastics economy and circular fashion by manufacturing 100% recycled polyethylene terephthalate  plastic and textile-to-textile polyester fiber, today announced that Daniel Solomita, Founder and CEO, and Kevin O'Dowd, Head of Investor Relations, will be participating in Gabelli Funds' 11th Annual Waste & Sustainability Symposium.Event Details:. During the conference, Loop will hold a group presentation and engage in one-on-one meetings with institutional investors and financial analysts.For More Information:Kevin C. O'Dowd, Investor RelationsLoop Industries, Inc.+1 617-755-4602kodowd@loopindustries.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/loop-industries-participate-gabelli-funds-120000283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4090","PET","LOOP","BK4192"],"gpt_icon":0},{"id":"2522780515","title":"Wag! Group Full Year 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2522780515","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522780515?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:49","pubTimestamp":1742993361,"startTime":"0","endTime":"0","summary":"AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.NasdaqGM:PET Earnings and Revenue History March 26th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 11%.The company's shares are down 22% from a week ago.You should learn about the   6 warning signs  we've spotted with Wag!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wag-group-full-2024-earnings-124921444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PETWW","PET"],"gpt_icon":0},{"id":"2522752706","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2522752706","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522752706?lang=en_us&edition=fundamental","pubTime":"2025-03-25 02:37","pubTimestamp":1742841460,"startTime":"0","endTime":"0","summary":"23andMe  filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive, less than a month after she attempted to acquire the genetic testing firm.Shares slumped 57%, with intraday trading volume of over 5.5 million against a daily average of about 292,000.TransCode Therapeutics  said Sunday it agreed to sell 10.25 million shares and warrants to buy up to 10.25 million shares at $0.98 per share and warrant to raise some $10 million.Shares sank 38% as intraday trading volume rose to over 15.5 million from a daily average of about 6.36 million.Wag!Group  said Monday its board is advancing a review of \"strategic alternatives to identify opportunities to maximize value for shareholders, including potential investments, strategic partnerships, sale, merger, or other strategic transactions involving the company or its assets.\"Shares slid 22% as intraday trading volume rose to over 1.3 million from a daily average of about 665,0","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNAZ","BK4539","ME","BK7047","BK4192","PET.AU","BK4121","BK4196","PET","MEHCQ","BK4139"],"gpt_icon":1},{"id":"2521972438","title":"Wag! Group Co reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2521972438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521972438?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:31","pubTimestamp":1742823111,"startTime":"0","endTime":"0","summary":"Group Co reports results for the quarter ended December 31 - Earnings SummaryWag!Group Co PET.OQ reported a quarterly adjusted loss of 9 cents per share for the quarter ended December 31, identical to the same quarter last year.  The mean expectation of two analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -8 cents to -2 cents per share.Revenue fell 28.8% to $15.43 million from a year ago; analysts expected $18.90 million. Wag!Group Co's reported EPS for the quarter was a loss of 10 cents.The company reported a quarterly loss of $4.81 million.Wag!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q713V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2521174698","title":"Wag! Group 2025 Outlook: Expects Revenues Of $84M-$88M Vs. $75.30M Est., Sees Adjusted EBITDA Of $2M-$4M","url":"https://stock-news.laohu8.com/highlight/detail?id=2521174698","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521174698?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:04","pubTimestamp":1742814276,"startTime":"0","endTime":"0","summary":"GuidanceFor the full year 2025, we expect:Revenues in the range of $84 million to $88 million.Adjusted EBITDA1 in the range of $2.0 million to $4.0 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44454636/wag-group-2025-outlook-expects-revenues-of-84m-88m-vs-75-30m-est-sees-adjusted-ebitda-of-2m-4m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2521745081","title":"Wag Group Q4 2024 GAAP EPS $(0.10) Misses $(0.05) Estimate, Sales $15.43M Miss $18.90M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745081","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745081?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:01","pubTimestamp":1742814114,"startTime":"0","endTime":"0","summary":"Wag Group (NASDAQ:PET) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.05) by 100 percent. This is a 11.11 percent decrease over losses of $(0.09) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44454598/wag-group-q4-2024-gaap-eps-0-10-misses-0-05-estimate-sales-15-43m-miss-18-90m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2521774682","title":"Wag! Group Co: Q4 Loss per Share $0.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2521774682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521774682?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX5AB337:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","PET"],"gpt_icon":0},{"id":"2521456897","title":"Wag! Group Q4 Revenue USD 15.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2521456897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521456897?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX5AB337:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2521745693","title":"Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745693","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745693?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA2GVWYF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","PET"],"gpt_icon":0},{"id":"2521745459","title":"Press Release: Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745459","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745459?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value. \"; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced financial results for the fourth quarter and full year ended December 31, 2024. The Company also announced that its Board of Directors  is advancing its review of strategic alternatives to identify opportunities to maximize value for shareholders, including potential investments, strategic partnerships, sale, merger, or other strategic transactions involving the Company or its assets.\"Our Board and management team continues to believe in the strength of our business, the effectiveness of our strategic plan, and our ability to execute on our strategy to drive value for shareholders,\" said Garrett Smallwood, CEO and Chairman of Wag!. \"We remain focused on strengthening our balance sheet and reducing our deb","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["Z4D.SI","BK6088","BK6046","BK4192","PET"],"gpt_icon":0},{"id":"2521586307","title":"Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2521586307","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521586307?lang=en_us&edition=fundamental","pubTime":"2025-03-24 10:33","pubTimestamp":1742783582,"startTime":"0","endTime":"0","summary":"The first of two of Opthea’s eye disease trials has failed to meet its primary endpoints. Hitiq has signed a deal with a key Australian Rules amateur league to supply its smart concussion mouthguards. Telix’s FDA news is good for prostate cancer patients in remote areas","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/03/image-3-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/03/image-3-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-optheas-solvency-is-in-question-following-monumental-phase-iii-eye-disease-trial-failure/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["III","BK4139","OPT","BK4585","PSA","BK4134","BK4588","PET","BK4192","BK4084","BK4217","BK4533"],"gpt_icon":0},{"id":"2521289203","title":"Wag! Group Co  expected to post a loss of 5 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289203","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289203?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:04","pubTimestamp":1742562245,"startTime":"0","endTime":"0","summary":"Group Co  expected to post a loss of5cents a share - Earnings Preview Wag!Group Co PET.OQ PET.O is expected to show a fall in quarterly revenue when it reports  results on March 24 for the period ending December 31 2024The San Francisco California-based  company is expected to report a 12.8% decrease in revenue to $18.9 million from $21.67 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst estimate for Wag!Group Co is for a loss of 5 cents per share. The one available analyst rating on the shares is \"hold\".  The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Wag!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q415S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":123}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PET\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-24","symbol":"PET","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2024-11-13","symbol":"PET","fiscalQuarterEnding":"2024/09","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-08-07","symbol":"PET","fiscalQuarterEnding":"2024/06","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.06},{"date":"2024-07-10","symbol":"PET","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1720598400000,"name":null,"time":"Pre-Market","dateTimestamp":1720584000000,"actualEps":null},{"market":"US","date":"2024-05-09","symbol":"PET","fiscalQuarterEnding":"2024/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PET","date":"2025-04-01","current":-0.44213,"percent":1,"low":-51.918761,"twenty":-24.608818,"median":-4.688704,"eighty":-1.939062,"high":-0.44213,"avg":-10.382994,"sd":10.942054,"marketCap":7767348},"quantilePoints":[{"date":"2021-10-01","current":-7.916755,"twenty":-7.916755,"median":-7.908627,"eighty":-7.901458,"marketCap":149143750},{"date":"2021-10-08","current":-7.941139,"twenty":-7.942895,"median":-7.928947,"eighty":-7.908627,"marketCap":149603125},{"date":"2021-10-15","current":-7.900499,"twenty":-7.941172,"median":-7.916755,"eighty":-7.900499,"marketCap":148837500},{"date":"2021-10-22","current":-7.908627,"twenty":-7.941139,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-10-29","current":-7.908627,"twenty":-7.934637,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-11-05","current":-7.941139,"twenty":-7.941139,"median":-7.916755,"eighty":-7.900499,"marketCap":149603125},{"date":"2021-11-12","current":-7.949267,"twenty":-7.941139,"median":-7.924883,"eighty":-7.907001,"marketCap":149756250},{"date":"2021-11-19","current":-7.965524,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":150062500},{"date":"2021-11-26","current":-8.185579,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":154208125},{"date":"2021-12-03","current":-8.143943,"twenty":-7.965524,"median":-7.941139,"eighty":-7.908627,"marketCap":153423750},{"date":"2021-12-10","current":-8.110635,"twenty":-8.123958,"median":-7.941139,"eighty":-7.908627,"marketCap":152796250},{"date":"2021-12-17","current":-8.111634,"twenty":-8.143943,"median":-7.941139,"eighty":-7.908627,"marketCap":152815075},{"date":"2021-12-23","current":-8.135616,"twenty":-8.143943,"median":-7.949267,"eighty":-7.908627,"marketCap":153266875},{"date":"2021-12-31","current":-8.143943,"twenty":-8.143943,"median":-7.949267,"eighty":-7.911878,"marketCap":153423750},{"date":"2022-01-07","current":-25.77251,"twenty":-8.143943,"median":-7.957396,"eighty":-7.916755,"marketCap":153423750},{"date":"2022-01-14","current":-25.746157,"twenty":-8.168925,"median":-7.965524,"eighty":-7.916755,"marketCap":153266875},{"date":"2022-01-21","current":-25.746157,"twenty":-8.185579,"median":-7.977716,"eighty":-7.918381,"marketCap":153266875},{"date":"2022-01-28","current":-25.746157,"twenty":-25.693453,"median":-8.111634,"eighty":-7.924883,"marketCap":153266875},{"date":"2022-02-04","current":-25.825214,"twenty":-25.746157,"median":-8.115298,"eighty":-7.926509,"marketCap":153737500},{"date":"2022-02-11","current":-25.956975,"twenty":-25.746157,"median":-8.135616,"eighty":-7.933011,"marketCap":154521875},{"date":"2022-02-18","current":-25.904271,"twenty":-25.746157,"median":-8.143943,"eighty":-7.933011,"marketCap":154208125},{"date":"2022-02-25","current":-25.851566,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":153894375},{"date":"2022-03-04","current":-25.930623,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":154365000},{"date":"2022-03-11","current":-25.956975,"twenty":-25.825214,"median":-8.143943,"eighty":-7.941139,"marketCap":154521875},{"date":"2022-03-18","current":-26.115089,"twenty":-25.825214,"median":-8.160598,"eighty":-7.941139,"marketCap":155463125},{"date":"2022-03-25","current":-26.036032,"twenty":-25.851566,"median":-8.177252,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-01","current":-26.036032,"twenty":-25.877919,"median":-8.185579,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-08","current":-26.036032,"twenty":-25.904271,"median":-16.939516,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-14","current":-26.220498,"twenty":-25.956975,"median":-25.700041,"eighty":-7.941139,"marketCap":156090625},{"date":"2022-04-22","current":-26.036032,"twenty":-25.956975,"median":-25.746157,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-29","current":-26.088737,"twenty":-26.00968,"median":-25.746157,"eighty":-7.941269,"marketCap":155306250},{"date":"2022-05-06","current":-26.036032,"twenty":-26.01495,"median":-25.746157,"eighty":-7.947674,"marketCap":154992500},{"date":"2022-05-13","current":-24.509388,"twenty":-26.01495,"median":-25.746157,"eighty":-7.949267,"marketCap":154678750},{"date":"2022-05-20","current":-24.534246,"twenty":-26.00968,"median":-25.746157,"eighty":-7.949267,"marketCap":154835625},{"date":"2022-05-27","current":-24.68339,"twenty":-26.00968,"median":-25.719805,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-03","current":-24.68339,"twenty":-26.00968,"median":-25.693453,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-10","current":-24.583961,"twenty":-26.00968,"median":-24.68339,"eighty":-7.954144,"marketCap":155149375},{"date":"2022-06-17","current":-24.608818,"twenty":-26.00968,"median":-24.68339,"eighty":-7.957396,"marketCap":155306250},{"date":"2022-06-24","current":-24.708248,"twenty":-25.988598,"median":-24.68339,"eighty":-7.960647,"marketCap":155933750},{"date":"2022-07-01","current":-24.608818,"twenty":-25.956975,"median":-24.658533,"eighty":-7.965524,"marketCap":155306250},{"date":"2022-07-08","current":-24.733105,"twenty":-25.956975,"median":-24.658533,"eighty":-7.96715,"marketCap":156090625},{"date":"2022-07-15","current":-24.757962,"twenty":-25.956975,"median":-24.68339,"eighty":-7.975278,"marketCap":156247500},{"date":"2022-07-22","current":-24.807677,"twenty":-25.956975,"median":-24.68339,"eighty":-8.007551,"marketCap":156561250},{"date":"2022-07-29","current":-25.105966,"twenty":-25.956975,"median":-24.68339,"eighty":-8.110835,"marketCap":158443750},{"date":"2022-08-05","current":-19.587625,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":123617500},{"date":"2022-08-12","current":-46.571248,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":293911149},{"date":"2022-08-19","current":-31.187311,"twenty":-26.00968,"median":-24.68339,"eighty":-8.1131,"marketCap":196823120},{"date":"2022-08-26","current":-29.685032,"twenty":-26.00968,"median":-24.708248,"eighty":-8.118962,"marketCap":187342238},{"date":"2022-09-02","current":-34.550721,"twenty":-26.036032,"median":-24.733105,"eighty":-8.122293,"marketCap":159278826},{"date":"2022-09-09","current":-42.365766,"twenty":-26.036032,"median":-24.757962,"eighty":-8.135616,"marketCap":195306179},{"date":"2022-09-16","current":-44.175565,"twenty":-26.036032,"median":-24.78282,"eighty":-8.135616,"marketCap":203649356},{"date":"2022-09-23","current":-20.154587,"twenty":-26.036032,"median":-24.78282,"eighty":-8.143943,"marketCap":92912648},{"date":"2022-09-30","current":-16.864043,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":77743236},{"date":"2022-10-07","current":-20.812696,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":95946530},{"date":"2022-10-14","current":-24.020978,"twenty":-26.036032,"median":-24.708248,"eighty":-8.143943,"marketCap":110736707},{"date":"2022-10-21","current":-32.45159,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":149601831},{"date":"2022-10-28","current":-34.873351,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":160766146},{"date":"2022-11-04","current":-27.317458,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":125933481},{"date":"2022-11-11","current":-2.304056,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":108509519},{"date":"2022-11-18","current":-2.038504,"twenty":-26.115089,"median":-24.757962,"eighty":-8.143943,"marketCap":96003337},{"date":"2022-11-25","current":-1.9604,"twenty":-26.115089,"median":-24.733105,"eighty":-8.132285,"marketCap":92325048},{"date":"2022-12-02","current":-1.991642,"twenty":-26.094007,"median":-24.708248,"eighty":-8.111634,"marketCap":93796364},{"date":"2022-12-09","current":-1.62846,"twenty":-26.046573,"median":-24.68339,"eighty":-7.972026,"marketCap":76692321},{"date":"2022-12-16","current":-1.679227,"twenty":-26.036032,"median":-24.68339,"eighty":-7.95577,"marketCap":79083209},{"date":"2022-12-23","current":-2.436832,"twenty":-26.036032,"median":-24.658533,"eighty":-7.949267,"marketCap":114762610},{"date":"2022-12-30","current":-2.405591,"twenty":-26.036032,"median":-24.658533,"eighty":-7.941139,"marketCap":113291295},{"date":"2023-01-06","current":-2.069667,"twenty":-26.036032,"median":-24.633675,"eighty":-7.941139,"marketCap":97470974},{"date":"2023-01-13","current":-2.218142,"twenty":-26.036032,"median":-24.621246,"eighty":-7.933011,"marketCap":104463401},{"date":"2023-01-20","current":-2.17128,"twenty":-26.036032,"median":-24.608818,"eighty":-7.926509,"marketCap":102256428},{"date":"2023-01-27","current":-2.530556,"twenty":-26.036032,"median":-24.608818,"eighty":-7.916755,"marketCap":119176557},{"date":"2023-02-03","current":-2.155659,"twenty":-26.036032,"median":-24.608818,"eighty":-7.908627,"marketCap":101520770},{"date":"2023-02-10","current":-1.851055,"twenty":-26.036032,"median":-24.608818,"eighty":-7.902125,"marketCap":87175444},{"date":"2023-02-17","current":-1.874486,"twenty":-26.036032,"median":-24.571532,"eighty":-7.893997,"marketCap":88278931},{"date":"2023-02-24","current":-2.245322,"twenty":-26.036032,"median":-24.559103,"eighty":-2.530556,"marketCap":86595328},{"date":"2023-03-03","current":-2.245322,"twenty":-26.036032,"median":-24.534246,"eighty":-2.452453,"marketCap":86595328},{"date":"2023-03-10","current":-1.614721,"twenty":-26.036032,"median":-24.534246,"eighty":-2.413401,"marketCap":62274938},{"date":"2023-03-17","current":-1.94913,"twenty":-26.036032,"median":-24.534246,"eighty":-2.38997,"marketCap":75172115},{"date":"2023-03-24","current":-2.197549,"twenty":-26.036032,"median":-24.509388,"eighty":-2.340867,"marketCap":84752874},{"date":"2023-03-31","current":-2.140222,"twenty":-26.036032,"median":-24.020978,"eighty":-2.293095,"marketCap":82541930},{"date":"2023-04-06","current":-2.111558,"twenty":-26.036032,"median":-23.445132,"eighty":-2.245322,"marketCap":81436457},{"date":"2023-04-14","current":-2.159331,"twenty":-26.036032,"median":-22.561,"eighty":-2.225952,"marketCap":83278911},{"date":"2023-04-21","current":-2.203009,"twenty":-26.01495,"median":-21.964387,"eighty":-2.217056,"marketCap":84963432},{"date":"2023-04-28","current":-2.270943,"twenty":-26.00968,"median":-20.697308,"eighty":-2.210332,"marketCap":87583450},{"date":"2023-05-05","current":-2.021661,"twenty":-26.00968,"median":-19.99006,"eighty":-2.209686,"marketCap":77969386},{"date":"2023-05-12","current":-2.248784,"twenty":-26.00968,"median":-19.907797,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-19","current":-2.248784,"twenty":-26.00968,"median":-19.587625,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-26","current":-1.874257,"twenty":-26.00968,"median":-19.301764,"eighty":-2.197549,"marketCap":74977784},{"date":"2023-06-02","current":-2.174138,"twenty":-25.978057,"median":-18.097997,"eighty":-2.197549,"marketCap":86974229},{"date":"2023-06-09","current":-2.061683,"twenty":-25.956975,"median":-16.864043,"eighty":-2.186237,"marketCap":82475562},{"date":"2023-06-16","current":-2.127282,"twenty":-25.956975,"median":-8.185579,"eighty":-2.180933,"marketCap":85099784},{"date":"2023-06-23","current":-2.04294,"twenty":-25.956975,"median":-8.185579,"eighty":-2.17128,"marketCap":81725784},{"date":"2023-06-29","current":-1.958599,"twenty":-25.956975,"median":-8.185579,"eighty":-2.164767,"marketCap":78351784},{"date":"2023-07-07","current":-1.883628,"twenty":-25.956975,"median":-8.168925,"eighty":-2.16347,"marketCap":75352672},{"date":"2023-07-14","current":-1.893,"twenty":-25.956975,"median":-8.148107,"eighty":-2.155659,"marketCap":75727561},{"date":"2023-07-21","current":-2.04294,"twenty":-25.956975,"median":-8.143943,"eighty":-2.147849,"marketCap":81725784},{"date":"2023-07-28","current":-2.108539,"twenty":-25.956975,"median":-8.143943,"eighty":-2.139508,"marketCap":84350007},{"date":"2023-08-04","current":-2.267851,"twenty":-25.941164,"median":-8.143943,"eighty":-2.138794,"marketCap":90723118},{"date":"2023-08-11","current":-2.32208,"twenty":-25.920074,"median":-8.135616,"eighty":-2.137501,"marketCap":99345563},{"date":"2023-08-18","current":-2.075795,"twenty":-25.907779,"median":-8.118962,"eighty":-2.137501,"marketCap":88808739},{"date":"2023-08-25","current":-2.053134,"twenty":-25.904271,"median":-8.111634,"eighty":-2.127997,"marketCap":87839211},{"date":"2023-09-01","current":-1.840115,"twenty":-25.904271,"median":-8.046207,"eighty":-2.121113,"marketCap":78725651},{"date":"2023-09-08","current":-1.903567,"twenty":-25.903322,"median":-7.973652,"eighty":-2.112829,"marketCap":81440328},{"date":"2023-09-15","current":-1.758534,"twenty":-25.899527,"median":-7.965524,"eighty":-2.108539,"marketCap":75235351},{"date":"2023-09-22","current":-1.695082,"twenty":-25.877919,"median":-7.953331,"eighty":-2.093176,"marketCap":72520673},{"date":"2023-09-29","current":-1.740405,"twenty":-25.851566,"median":-7.949267,"eighty":-2.080425,"marketCap":74459729},{"date":"2023-10-06","current":-1.704146,"twenty":-25.851566,"median":-7.945284,"eighty":-2.069745,"marketCap":72908484},{"date":"2023-10-13","current":-1.676952,"twenty":-25.851566,"median":-7.941139,"eighty":-2.061683,"marketCap":71745051},{"date":"2023-10-20","current":-1.60933,"twenty":-25.851566,"median":-7.941139,"eighty":-2.052312,"marketCap":68851980},{"date":"2023-10-27","current":-1.568177,"twenty":-25.851566,"median":-7.941139,"eighty":-2.045204,"marketCap":67091318},{"date":"2023-11-03","current":-1.560563,"twenty":-25.851566,"median":-7.933011,"eighty":-2.038504,"marketCap":66765557},{"date":"2023-11-10","current":-16.478139,"twenty":-25.851566,"median":-7.933011,"eighty":-2.036475,"marketCap":66703507},{"date":"2023-11-17","current":-17.055401,"twenty":-25.841025,"median":-7.941139,"eighty":-2.038504,"marketCap":69040264},{"date":"2023-11-24","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.038504,"marketCap":69071661},{"date":"2023-12-01","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.039391,"marketCap":69071661},{"date":"2023-12-08","current":-16.966208,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68679208},{"date":"2023-12-15","current":-16.869258,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68286755},{"date":"2023-12-22","current":-17.257057,"twenty":-25.819944,"median":-7.957396,"eighty":-2.044072,"marketCap":69856566},{"date":"2023-12-29","current":-16.966208,"twenty":-25.804132,"median":-7.96146,"eighty":-2.047469,"marketCap":68679208},{"date":"2024-01-05","current":-17.063157,"twenty":-25.798862,"median":-7.965524,"eighty":-2.050085,"marketCap":69071661},{"date":"2024-01-12","current":-16.384509,"twenty":-25.798862,"median":-8.046207,"eighty":-2.052312,"marketCap":66324492},{"date":"2024-01-19","current":-17.450956,"twenty":-25.793592,"median":-8.111634,"eighty":-2.052312,"marketCap":70641471},{"date":"2024-01-26","current":-19.293002,"twenty":-25.77251,"median":-8.118962,"eighty":-2.052476,"marketCap":78098071},{"date":"2024-02-02","current":-19.370562,"twenty":-25.77251,"median":-8.135616,"eighty":-2.054844,"marketCap":78412033},{"date":"2024-02-09","current":-17.935705,"twenty":-25.77251,"median":-8.143943,"eighty":-2.061683,"marketCap":72603734},{"date":"2024-02-16","current":-6.45394,"twenty":-25.77251,"median":-8.143943,"eighty":-2.06328,"marketCap":85947123},{"date":"2024-02-23","current":-5.95295,"twenty":-25.77251,"median":-8.139779,"eighty":-2.069667,"marketCap":79275429},{"date":"2024-03-01","current":-5.894009,"twenty":-25.77251,"median":-8.118962,"eighty":-2.069745,"marketCap":78490524},{"date":"2024-03-08","current":-6.33606,"twenty":-25.746157,"median":-8.111634,"eighty":-2.069745,"marketCap":84377313},{"date":"2024-03-15","current":-6.12977,"twenty":-25.746157,"median":-8.110635,"eighty":-2.075795,"marketCap":81630144},{"date":"2024-03-22","current":-5.894009,"twenty":-25.746157,"median":-7.969588,"eighty":-2.077556,"marketCap":78490524},{"date":"2024-03-28","current":-5.658249,"twenty":-25.746157,"median":-7.96146,"eighty":-2.077556,"marketCap":75350903},{"date":"2024-04-05","current":-6.089301,"twenty":-25.746157,"median":-7.949267,"eighty":-2.079851,"marketCap":81091218},{"date":"2024-04-12","current":-6.392251,"twenty":-25.746157,"median":-7.949267,"eighty":-2.080425,"marketCap":85125607},{"date":"2024-04-19","current":-6.301366,"twenty":-25.746157,"median":-7.941302,"eighty":-2.084378,"marketCap":83915291},{"date":"2024-04-26","current":-6.664906,"twenty":-25.746157,"median":-7.941139,"eighty":-2.091032,"marketCap":88756558},{"date":"2024-05-03","current":-6.831529,"twenty":-25.746157,"median":-7.941139,"eighty":-2.093031,"marketCap":90975471},{"date":"2024-05-10","current":-7.133641,"twenty":-25.746157,"median":-7.937075,"eighty":-2.09797,"marketCap":98237372},{"date":"2024-05-17","current":-5.947142,"twenty":-25.746157,"median":-7.933011,"eighty":-2.099168,"marketCap":81898096},{"date":"2024-05-24","current":-4.687403,"twenty":-25.735616,"median":-7.924883,"eighty":-2.106665,"marketCap":64550224},{"date":"2024-05-31","current":-4.572017,"twenty":-25.71717,"median":-7.916755,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-07","current":-4.572017,"twenty":-25.698723,"median":-7.908627,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-14","current":-4.513024,"twenty":-25.693453,"median":-7.908627,"eighty":-2.108642,"marketCap":62148847},{"date":"2024-06-21","current":-4.365539,"twenty":-25.580927,"median":-7.908627,"eighty":-2.109349,"marketCap":60117839},{"date":"2024-06-28","current":-4.92598,"twenty":-25.355875,"median":-7.908627,"eighty":-2.110454,"marketCap":67835670},{"date":"2024-07-05","current":-4.719502,"twenty":-25.12088,"median":-7.900499,"eighty":-2.114099,"marketCap":64992259},{"date":"2024-07-12","current":-4.45403,"twenty":-24.996593,"median":-7.900499,"eighty":-2.119192,"marketCap":61336444},{"date":"2024-07-15","current":-4.719502,"twenty":-24.941907,"median":-7.900499,"eighty":-2.119832,"marketCap":64992259},{"date":"2024-08-02","current":-3.480633,"twenty":-24.88722,"median":-7.896435,"eighty":-2.120473,"marketCap":47931791},{"date":"2024-08-09","current":-3.44267,"twenty":-24.832534,"median":-7.872782,"eighty":-2.121113,"marketCap":41838766},{"date":"2024-08-16","current":-3.734947,"twenty":-24.812648,"median":-6.984832,"eighty":-2.126048,"marketCap":45390806},{"date":"2024-08-23","current":-3.084343,"twenty":-24.807677,"median":-6.876972,"eighty":-2.127282,"marketCap":37484020},{"date":"2024-08-30","current":-3.413661,"twenty":-24.787791,"median":-6.869398,"eighty":-2.127282,"marketCap":41486221},{"date":"2024-09-06","current":-3.375508,"twenty":-24.78282,"median":-6.801234,"eighty":-2.127997,"marketCap":41022551},{"date":"2024-09-13","current":-2.972696,"twenty":-24.767905,"median":-6.725496,"eighty":-2.129789,"marketCap":36127177},{"date":"2024-09-20","current":-3.449806,"twenty":-24.757962,"median":-6.635604,"eighty":-2.134259,"marketCap":41925487},{"date":"2024-09-27","current":-3.545388,"twenty":-24.743048,"median":-6.543726,"eighty":-2.136653,"marketCap":43087101},{"date":"2024-10-04","current":-3.48595,"twenty":-24.733105,"median":-6.48341,"eighty":-2.137501,"marketCap":42364752},{"date":"2024-10-11","current":-3.353821,"twenty":-24.733105,"median":-6.45394,"eighty":-2.13936,"marketCap":40758992},{"date":"2024-10-18","current":-3.413661,"twenty":-24.718191,"median":-6.392251,"eighty":-2.140222,"marketCap":41486221},{"date":"2024-10-25","current":-3.226914,"twenty":-24.708248,"median":-6.361956,"eighty":-2.143518,"marketCap":39216680},{"date":"2024-10-31","current":-2.961451,"twenty":-24.708248,"median":-6.331661,"eighty":-2.146569,"marketCap":35990517},{"date":"2024-11-08","current":-2.552615,"twenty":-24.698305,"median":-6.303978,"eighty":-2.147849,"marketCap":31021931},{"date":"2024-11-15","current":-0.547386,"twenty":-24.68339,"median":-6.27712,"eighty":-2.146569,"marketCap":8878051},{"date":"2024-11-22","current":-0.606003,"twenty":-24.68339,"median":-6.22989,"eighty":-2.137218,"marketCap":9828767},{"date":"2024-11-29","current":-0.659113,"twenty":-24.68339,"median":-6.184448,"eighty":-2.128912,"marketCap":10690153},{"date":"2024-12-06","current":-0.685514,"twenty":-24.68339,"median":-6.12977,"eighty":-2.122347,"marketCap":11118357},{"date":"2024-12-13","current":-0.70639,"twenty":-24.678419,"median":-6.080065,"eighty":-2.109349,"marketCap":11456936},{"date":"2024-12-20","current":-0.621353,"twenty":-24.658533,"median":-6.04136,"eighty":-2.101042,"marketCap":10077722},{"date":"2024-12-27","current":-0.728186,"twenty":-24.658533,"median":-6.035031,"eighty":-2.092449,"marketCap":11810453},{"date":"2025-01-03","current":-0.874929,"twenty":-24.658533,"median":-6.01189,"eighty":-2.079851,"marketCap":14190469},{"date":"2025-01-10","current":-0.83195,"twenty":-24.658533,"median":-5.968121,"eighty":-2.073375,"marketCap":13493393},{"date":"2025-01-17","current":-0.801251,"twenty":-24.643618,"median":-5.93531,"eighty":-2.061683,"marketCap":12995482},{"date":"2025-01-24","current":-0.788664,"twenty":-24.633675,"median":-5.894009,"eighty":-2.052312,"marketCap":12791338},{"date":"2025-01-31","current":-0.791427,"twenty":-24.633675,"median":-5.894009,"eighty":-2.04294,"marketCap":12836150},{"date":"2025-02-07","current":-0.997726,"twenty":-24.623732,"median":-5.776129,"eighty":-2.038504,"marketCap":16182114},{"date":"2025-02-14","current":-1.099033,"twenty":-24.608818,"median":-5.658249,"eighty":-2.027617,"marketCap":17825220},{"date":"2025-02-21","current":-0.92282,"twenty":-24.608818,"median":-5.628779,"eighty":-2.021458,"marketCap":14967210},{"date":"2025-02-28","current":-0.775463,"twenty":-24.608818,"median":-5.099654,"eighty":-1.992156,"marketCap":12577236},{"date":"2025-03-07","current":-0.775156,"twenty":-24.608818,"median":-4.778496,"eighty":-1.977341,"marketCap":12572257},{"date":"2025-03-14","current":-0.75643,"twenty":-24.608818,"median":-4.719502,"eighty":-1.959028,"marketCap":12268531},{"date":"2025-03-21","current":-0.722967,"twenty":-24.608818,"median":-4.719502,"eighty":-1.953792,"marketCap":11725808},{"date":"2025-03-28","current":-0.540029,"twenty":-24.608818,"median":-4.704754,"eighty":-1.94913,"marketCap":9487224},{"date":"2025-04-01","current":-0.44213,"twenty":-24.608818,"median":-4.688704,"eighty":-1.939062,"marketCap":7767348}],"updateTime":1743619636106}}}